|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.99 CNY | -2.47% |
|
-6.06% | -26.31% |
| May. 18 | Bide Pharmatech's shareholders to unload stake in co | RE |
| Apr. 29 | Bide Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 3.88B 573M 494M 454M 426M 801M 54.12B 809M 5.37B 2.1B 26.5B 2.15B 2.1B 91.71B | P/E Ratio 2026 * |
17x | P/E Ratio 2027 * | 13x |
|---|---|---|---|---|---|
| Enterprise Value | 3.88B 573M 494M 454M 426M 801M 54.12B 809M 5.37B 2.1B 26.5B 2.15B 2.1B 91.71B | EV / Sales 2026 * |
2.32x | EV / Sales 2027 * | 1.89x |
| Free-Float |
39.44% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.47% | ||
| 1 week | -6.06% | ||
| Current month | -11.47% | ||
| 1 month | -19.37% | ||
| 3 months | -22.15% | ||
| 6 months | -33.34% | ||
| Current year | -26.31% |
| 1 week | 44.22 |  | 47.1 |
| 1 month | 44.22 | | 57.33 |
| Current year | 44.22 | | 77.81 |
| 1 year | 44.22 | | 82.88 |
| 3 years | 28.5 | | 82.88 |
| 5 years | 28.5 | | 114.05 |
| 10 years | 28.5 | | 114.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lan Dai
CEO | Chief Executive Officer | - | 2023-10-12 |
Rong Hao Li
CTO | Chief Tech/Sci/R&D Officer | 43 | 2008-03-31 |
Chao Wang
CTO | Chief Tech/Sci/R&D Officer | 43 | 2008-02-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Hong Meng
BRD | Director/Board Member | 60 | 2023-10-12 |
Lan Dai
CHM | Chairman | - | 2023-10-12 |
Tao Li
BRD | Director/Board Member | 40 | 2023-10-12 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.47% | -6.06% | -7.85% | -38.50% | 587M | |
| +0.96% | +1.16% | -12.70% | -12.33% | 43.03B | |
| +3.95% | +7.39% | +300.96% | +534.29% | 32.71B | |
| -1.67% | -2.78% | +12.14% | -17.62% | 30.29B | |
| +0.40% | -1.89% | +0.48% | +32.16% | 29.4B | |
| +1.16% | +2.10% | +14.27% | +22.05% | 25.08B | |
| +2.37% | +8.52% | - | - | 13.54B | |
| -0.38% | +2.02% | +55.22% | +111.76% | 13.35B | |
| -1.09% | -2.31% | +3.49% | +5.00% | 12.97B | |
| +0.22% | -0.01% | +108.65% | +76.37% | 12.11B | |
| Average | +0.33% | +0.32% | +52.74% | +79.24% | 21.31B | |
| Weighted average by Cap. | +0.78% | +0.81% | +60.81% | +102.10% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.67B 247M 213M 196M 184M 345M 23.35B 349M 2.32B 905M 11.43B 927M 907M 39.56B | 2.06B 304M 262M 241M 226M 424M 28.7B 429M 2.85B 1.11B 14.05B 1.14B 1.12B 48.63B |
| Net income | 241M 35.61M 30.69M 28.25M 26.5M 49.77M 3.37B 50.27M 334M 130M 1.65B 134M 131M 5.7B | 314M 46.39M 39.99M 36.8M 34.52M 64.85M 4.38B 65.5M 435M 170M 2.15B 174M 170M 7.43B |
| Net Debt | - | - |
Employees
734
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-14 | 44.99 ¥ | -2.47% | 1,017,366 |
| 26-06-12 | 46.13 ¥ | +2.28% | 830,045 |
| 26-06-11 | 45.10 ¥ | -0.99% | 568,648 |
| 26-06-10 | 45.55 ¥ | -3.09% | 1,020,990 |
| 26-06-09 | 47.00 ¥ | +2.35% | 917,688 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
44.99
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 688073 Stock
Select your edition
All financial news and data tailored to specific country editions
